Industry Trends

Guanjie Biotech is pleased to announce that its jointly invested manufacturing facility with Tongxinxinda has been successfully completed and has officially entered into production. This milestone marks an important step in Guanjie Biotech’s long-term strategy to strengthen upstream manufacturing capabilities and further enhance supply stability, quality control, and innovation in the field of plant extracts.

The new Tongxinxinda factory is designed as a modern production base dedicated to the research, extraction, processing, and manufacturing of high-quality plant extract ingredients. Equipped with advanced production lines and standardized management systems, the facility supports large-scale, stable, and efficient manufacturing to meet the growing global demand from the food, nutraceutical, dietary supplement, cosmetic, and pharmaceutical industries.

As a joint venture, the factory integrates Guanjie Biotech's strong market experience, international trade expertise, and product development capabilities with Tongxinxinda's manufacturing know-how and operational strengths. This cooperation enables tighter control over the entire value chain, from raw material sourcing and extraction processes to quality inspection and final delivery. Through this model, Guanjie Biotech can provide customers with more consistent quality, improved traceability, and enhanced supply reliability.

The Tongxinxinda factory focuses on the production of a wide range of plant extracts, using carefully selected botanical raw materials and scientifically optimized extraction technologies. The production process emphasizes efficiency, safety, and sustainability, aiming to preserve the natural active components of plants while ensuring high purity and stable performance. The facility is designed to support different extraction methods, such as water extraction, ethanol extraction, and concentration and drying processes, allowing flexibility for diverse product specifications.

Quality management is a core priority of the new factory. The production site has successfully passed multiple international and industry-recognized certifications, reflecting its compliance with strict quality, safety, and operational standards. These certifications ensure that manufacturing practices meet global requirements and provide strong assurance to customers in different markets. From raw material inspection to in-process control and final product testing, every stage is managed under a rigorous quality control system.

With production now underway, the Tongxinxinda factory significantly strengthens Guanjie Biotech's supply capacity for plant extract products. The facility supports both standard products and customized solutions, enabling flexible cooperation with global partners. This allows Guanjie Biotech to better serve customers seeking stable bulk supply, private label development, or tailored ingredient specifications.

Looking ahead, Guanjie Biotech will continue to invest in technology upgrades, process optimization, and product innovation together with Tongxinxinda. The joint venture factory will serve as an important foundation for expanding the company’s plant extract portfolio and enhancing its competitiveness in the international market. By combining manufacturing strength with a customer-oriented approach, Guanjie Biotech remains committed to delivering high-quality, reliable, and compliant plant extract solutions to partners worldwide.